切换至 "中华医学电子期刊资源库"

中华移植杂志(电子版) ›› 2020, Vol. 14 ›› Issue (02) : 87 -91. doi: 10.3877/cma.j.issn.1674-3903.2020.02.006

所属专题: 文献

移植前沿

国际肺移植临床研究热点和亚洲肺移植发展现状
岳冰清1, 陈静瑜1,()   
  1. 1. 214023 无锡,南京医科大学附属无锡人民医院肺移植中心
  • 收稿日期:2019-12-09 出版日期:2020-04-25
  • 通信作者: 陈静瑜

Summary of the First Wuxi International Lung Transplantation Conference

Bingqing Yue1, Jingyu Chen1,()   

  1. 1. Lung Transplantation Center, Wuxi People′s Hospital Affiliated to Nanjing Medical University, Wuxi 214023, China
  • Received:2019-12-09 Published:2020-04-25
  • Corresponding author: Jingyu Chen
  • About author:
    Corresponding author: Chen Jingyu, Email:
引用本文:

岳冰清, 陈静瑜. 国际肺移植临床研究热点和亚洲肺移植发展现状[J/OL]. 中华移植杂志(电子版), 2020, 14(02): 87-91.

Bingqing Yue, Jingyu Chen. Summary of the First Wuxi International Lung Transplantation Conference[J/OL]. Chinese Journal of Transplantation(Electronic Edition), 2020, 14(02): 87-91.

重点概述首届国际肺移植论坛有关肺移植的临床研究热点和亚洲肺移植发展现状,包括HCV阳性供者供肺应用、肺移植术后并发症的处理、意大利心脏死亡器官捐献经验分享以及亚洲不同地区肺移植经验介绍等。通过国内外专家的经验交流,促进中国肺移植事业与国际接轨并不断发展。

This paper presents a summary of up-to-date knowledge of the First Wuxi International Lung Transplantation Conference. Recent advancement of lung transplantation and current situation of lung transplantation in Asia are introduced, including the application of donor lung from HCV infected donor, the management of complications after lung transplantation, experience sharing of lung transplantation with donor lung from donation after cardiac death in Italy and different parts of Asia, and so on. The exchange of experience of experts at home and abroad promotes the continuous development of lung transplantation in China and to be in line with international standards.

[1]
Carreno MC, Piedad UG, Maite L, et al. Hepatitis C virus infection after lung transplantation: dim prognosis[J]. J Heart Lung Transplant, 2001, 20(2): 224.
[2]
Englum BR, Ganapathi AM, Speicher PJ, et al. Impact of donor and recipient hepatitis C status in lung transplantation[J]. J Heart Lung Transplant, 2016,35(2):228-235.
[3]
D′Ambrosio R, Aghemo A, Rossetti V, et al. Sofosbuvir-based regimens for the treatment of hepatitis C virus in patients who underwent lung transplant: case series and review of the literature[J]. Liver Int, 2016,36(11):1585-1589.
[4]
Khan B, Singer LG, Lilly LB, et al. Successful lung transplantation from hepatitis C positive donor to seronegative recipient[J]. Am J Transplant, 2017,17(4):1129-1131.
[5]
Mansour M, Hill L, Kerr J. Safety and effectiveness of direct acting antivirals for treatment of hepatitis C virus in patients with solid organ transplantation[J]. Transpl Infect Dis, 2018,20(6):e12972.
[6]
Abdelbasit A, Hirji A, Halloran K, et al. Lung transplantation from hepatitis C viremic donors to uninfected recipients[J]. Am J Respir Crit Care Med, 2018,197(11):1492-1496.
[7]
Woolley AE, Singh SK, Goldberg HJ, et al. Heart and lung transplants from HCV-infected donors to uninfected recipients[J]. N Engl J Med, 2019,380(17):1606-1617.
[8]
Van De Wauwer C, Van Raemdonck D, Verleden GM, et al. Risk factors for airway complications within the first year after lung transplantation[J]. Eur J Cardiothorac Surg, 2007,31(4):703-710.
[9]
Yserbyt J, Dooms C, Vos R, et al. Anastomotic airway complications after lung transplantation: risk factors, treatment modalities and outcome-a single-centre experience[J]. Eur J Cardiothorac Surg, 2016,49(1):e1-e8.
[10]
Patterson GA, Todd TR, Cooper JD, et al. Airway complications after double lung transplantation. Toronto Lung Transplant Group[J]. J Thorac Cardiovasc Surg, 1990,99(1):14-20.
[11]
Palleschi A, Tosi D, Rosso L, et al. Successful preservation and transplant of warm ischaemic lungs from controlled donors after circulatory death by prolonged in situ ventilation during normothermic regional perfusion of abdominal organs[J]. Interact Cardiovasc Thorac Surg, 2019, 29(5): 699-705.
[12]
Jo KW, Hong SB, Kim DK, et al. Long-Term outcomes of adult lung transplantation recipients: a single-center experience in South Korea[J]. Tuberc Respir Dis (Seoul), 2019,82(4):348-356.
[1] 周易, 张红梅, 尹立雪, 杨浩, 付培. 四川省超声医学质量控制指标动态变化趋势分析[J/OL]. 中华医学超声杂志(电子版), 2024, 21(07): 664-670.
[2] 王晓娜, 张宁, 宋伟, 杨明, 李丽, 薛红元. 河北省超声医学质量管理与控制现状分析[J/OL]. 中华医学超声杂志(电子版), 2024, 21(07): 675-680.
[3] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[4] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[5] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[6] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[7] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[8] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[9] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[10] 许杰, 李亚俊, 冯义文. SOX新辅助化疗后腹腔镜胃癌D2根治术与常规根治术治疗进展期胃癌的近期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 647-650.
[11] 刘柏隆, 周祥福. 女性尿失禁吊带手术并发症处理的经验分享[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 127-127.
[12] 嵇振岭, 陈杰, 唐健雄. 重视复杂腹壁疝手术并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 601-606.
[13] 江志鹏, 钟克力, 陈双. 复杂腹壁疝手术后腹腔高压与腹腔间室综合征的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 612-615.
[14] 陈秀梅, 陈思涓, 郑小静. 护理联盟体构建及实践的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 703-708.
[15] 李茂军, 唐彬秩, 吴青, 阳倩, 梁小明, 邹福兰, 黄蓉, 陈昌辉. 新生儿呼吸窘迫综合征的管理:多国指南/共识及RDS-NExT workshop 共识陈述简介和评价[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 607-617.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?